Intensity‐modulated radiation therapy in head and neck cancers: The Mallinckrodt experience

The purpose of the study was to investigate the feasibility and the optimization of tomotherapy‐based intensity‐modulated radiation therapy (IMRT) in patients with head and neck cancer. From February 1997 to November 1997, 17 patients with squamous cell carcinoma of the head and neck were treated with IMRT. Patients were immobilized with a noninvasive mask and treated using a serial tomotherapy device on a 6 MV linear accelerator. Treatment planning was performed on a Peacock inverse planning system and prescription optimization was used to achieve the best plan for target coverage and parotid sparing. The treatment planning system process has a dosimetric characteristic of delivering different doses to different target structures simultaneously in each daily treatment; therefore, the biological equivalent dose was implemented using the linear‐quadratic model to adjust the total dose to the target volume receiving a daily dose of less than 1.9 Gy. All eight patients with gross disease (six in the nasopharynx, two in the tonsil) and one patient with recurrent nasopharyngeal carcinoma received concurrent cisplatin chemotherapy. Six postoperative patients were treated with irradiation alone. Median follow‐up was 2.2 years (range 2.6–1.8 years). All patients completed the prescribed treatment without unexpected interruption. Acute side effects were comparable to those of patients treated with conventional beam arrangements during the same period. No patient required gastrostomy during irradiation. The preliminary experience showed that the noninvasive immobilization mask yielded high positioning reproducibility for our patients. To spare the parotid gland, which is in the proximity of the target, a fraction of the target volume may not receive the prescribed dose. In the best‐achievable plan of our studied cohort, only 27% ± 8% of parotid gland volumes were treated to more than 30 Gy, while an average of 3.3% ± 0.6% of the target volume received less than 95% of the prescribed dose. This is mainly related to the steep dose gradient in the region where the target abuts the parotid gland. The inverse planning system allowed us the freedom of weighting normal tissue‐sparing and target coverage to select the best‐achievable plan. Local control was achieved in eight patients with gross tumor; six were treated postoperatively. Of three reirradiated patients, two had symptomatic improvement but persistent disease, and one is without evidence of disease. In summary, a system for patient immobilization, setup verification, and dose optimization for head and neck cancer with parotid sparing without significantly compromising target coverage is being implemented for a tomotherapy‐based IMRT plan at the Mallinckrodt Institute of Radiology. The initial clinical experience in tumor control is promising, and no severe adverse acute side effects have been observed. Further refining of delivery technology and the inverse planning system, gaining clinical experience to address target definition and dose inhomogeneity within the targets, and understanding the partial volume effect on normal tissue tolerance are needed for IMRT to excel in the treatment of head and neck cancer. Int. J. Cancer (Radiat. Oncol. Invest.) 90, 92–103, (2000). © 2000 Wiley‐Liss, Inc.

[1]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[2]  S L Meeks,et al.  Potential clinical efficacy of intensity-modulated conformal therapy. , 1998, International journal of radiation oncology, biology, physics.

[3]  R Mohan,et al.  Optimization of intensity-modulated 3D conformal treatment plans based on biological indices. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  I. Shannon MANAGEMENT OF HEAD AND NECK IRRADIATED PATIENTS , 1981 .

[5]  E. B. Butler,et al.  A comparison of intensity modulated conformal therapy with a conventional external beam stereotactic radiosurgery system for the treatment of single and multiple intracranial lesions. , 1996, International journal of radiation oncology, biology, physics.

[6]  A. P. James,et al.  1045 Clinical and technical considerations for head and neck cancers treated by IMRT: Initial experience , 1997 .

[7]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[8]  Hirohiko Tsuni Quantitative dose-response analysis of salivary function following radiotherapy using sequential RI-sialography , 1985 .

[9]  J. Tsai,et al.  Dosimetric verification of the dynamic intensity-modulated radiation therapy of 92 patients. , 1998, International journal of radiation oncology, biology, physics.

[10]  R Mohan,et al.  Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. , 1991, International journal of radiation oncology, biology, physics.

[11]  M. Martel,et al.  Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. , 1996, International journal of radiation oncology, biology, physics.

[12]  D. Herbert,et al.  The function of the parotid gland following radiation therapy for head and neck cancer. , 1981, International Journal of Radiation Oncology, Biology, Physics.

[13]  K. Ang,et al.  Acute and late radiation injury in rhesus monkey parotid glands. Evidence of interphase cell death. , 1986, The American journal of pathology.

[14]  D. Brizel Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma. , 1998, Seminars in radiation oncology.

[15]  D. Verellen,et al.  Initial experience with intensity-modulated conformal radiation therapy for treatment of the head and neck region. , 1997, International journal of radiation oncology, biology, physics.

[16]  K. Ang,et al.  Target cell and mode of radiation injury in rhesus salivary glands. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  D Verellen,et al.  Target localization and treatment verification for intensity modulated conformal radiation therapy of the head and neck region. The AZ-VUB experience. Akademisch Ziekenhuis-Vrije Universiteit Brussel. , 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[18]  C. Chao,et al.  Reirradiation of recurrent skin cancer of the face. A successful salvage modality , 1995, Cancer.

[19]  M. Leblanc,et al.  Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Purdy Ja Advances in three-dimensional treatment planning and conformal dose delivery. , 1997 .

[21]  Melvin L. Griem,et al.  Prescribing, Recording, and Reporting Photon Beam Therapy , 1994 .

[22]  S Mutic,et al.  Abutment region dosimetry for serial tomotherapy. , 1999, International journal of radiation oncology, biology, physics.

[23]  A R Bleier,et al.  The field-matching problem as it applies to the peacock three dimensional conformal system for intensity modulation. , 1996, International journal of radiation oncology, biology, physics.

[24]  A L Boyer,et al.  Modulated beam conformal therapy for head and neck tumors. , 1997, International journal of radiation oncology, biology, physics.

[25]  R G Dale,et al.  The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. , 1985, The British journal of radiology.

[26]  P. Wingo,et al.  Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.

[27]  C. Ling,et al.  Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. , 1997, International journal of radiation oncology, biology, physics.

[28]  H. Tsujii Quantitative dose-response analysis of salivary function following radiotherapy using sequential RI-sialography. , 1985, International journal of radiation oncology, biology, physics.